Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cardiovascular diseases and liver transplantation [[electronic resource] /] / Zoka Milan, editor
| Cardiovascular diseases and liver transplantation [[electronic resource] /] / Zoka Milan, editor |
| Pubbl/distr/stampa | New York, : Nova Science, c2011 |
| Descrizione fisica | 1 online resource (315 p.) |
| Disciplina | 617.5/562 |
| Altri autori (Persone) | MilanZoka |
| Collana | Cardiology research and clinical developments |
| Soggetto topico |
Liver - Failure - Complications
Liver - Transplantation - Complications Cardiological manifestations of general diseases Cardiovascular system - Diseases - Complications |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61942-704-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Contents""; ""Contributors""; ""Preface""; ""Abbreviations""; ""Haemodynamic Profile of Patients with End-Stage Liver Disease""; ""Coronary Artery Disease and Liver Transplantation""; ""Cardiac Arrhythmias and Liver Transplantation""; ""Valvular Heart Disease and Liver Transplantation""; ""Pulmonary Hypertension and Liver Transplantation""; ""Hypertrophic Obstructive Cardiomypathy in Liver Transplant Patients""; ""Obesity and Liver Transplantation""; ""Liver Disease and Chronic Advanced Heart Failure""; ""Combined Cardiac Surgery and Liver Transplantation""
""Previous Chemotherapy and Cardiac Function""""Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts""; ""Hepatopulmonary Syndrome""; ""Pre-Operative Assessment of Cardiovascular Function before Liver Transplantation: A Practical Approach""; ""A Role of Cardiopulmonary Exercise Testing (CPET) in Defining Cardiopulmonary Function before Liver Transplantation""; ""Pharmacotherapy of Cardiac Dysfunction in Liver Transplant Patients""; ""Cardiovascular Monitoring During Liver Transplantation"" ""Cardiovascular Profile and Cardiac Complications Following Liver Transplantation""""Acknowledgments""; ""Index"" |
| Record Nr. | UNINA-9910461308003321 |
| New York, : Nova Science, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular diseases and liver transplantation [[electronic resource] /] / Zoka Milan, editor
| Cardiovascular diseases and liver transplantation [[electronic resource] /] / Zoka Milan, editor |
| Pubbl/distr/stampa | New York, : Nova Science, c2011 |
| Descrizione fisica | 1 online resource (315 p.) |
| Disciplina | 617.5/562 |
| Altri autori (Persone) | MilanZoka |
| Collana | Cardiology research and clinical developments |
| Soggetto topico |
Liver - Failure - Complications
Liver - Transplantation - Complications Cardiological manifestations of general diseases Cardiovascular system - Diseases - Complications |
| ISBN | 1-61942-704-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Contents""; ""Contributors""; ""Preface""; ""Abbreviations""; ""Haemodynamic Profile of Patients with End-Stage Liver Disease""; ""Coronary Artery Disease and Liver Transplantation""; ""Cardiac Arrhythmias and Liver Transplantation""; ""Valvular Heart Disease and Liver Transplantation""; ""Pulmonary Hypertension and Liver Transplantation""; ""Hypertrophic Obstructive Cardiomypathy in Liver Transplant Patients""; ""Obesity and Liver Transplantation""; ""Liver Disease and Chronic Advanced Heart Failure""; ""Combined Cardiac Surgery and Liver Transplantation""
""Previous Chemotherapy and Cardiac Function""""Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts""; ""Hepatopulmonary Syndrome""; ""Pre-Operative Assessment of Cardiovascular Function before Liver Transplantation: A Practical Approach""; ""A Role of Cardiopulmonary Exercise Testing (CPET) in Defining Cardiopulmonary Function before Liver Transplantation""; ""Pharmacotherapy of Cardiac Dysfunction in Liver Transplant Patients""; ""Cardiovascular Monitoring During Liver Transplantation"" ""Cardiovascular Profile and Cardiac Complications Following Liver Transplantation""""Acknowledgments""; ""Index"" |
| Record Nr. | UNINA-9910790187703321 |
| New York, : Nova Science, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular diseases and liver transplantation [[electronic resource] /] / Zoka Milan, editor
| Cardiovascular diseases and liver transplantation [[electronic resource] /] / Zoka Milan, editor |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Science, c2011 |
| Descrizione fisica | 1 online resource (315 p.) |
| Disciplina | 617.5/562 |
| Altri autori (Persone) | MilanZoka |
| Collana | Cardiology research and clinical developments |
| Soggetto topico |
Liver - Failure - Complications
Liver - Transplantation - Complications Cardiological manifestations of general diseases Cardiovascular system - Diseases - Complications |
| ISBN | 1-61942-704-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Contents""; ""Contributors""; ""Preface""; ""Abbreviations""; ""Haemodynamic Profile of Patients with End-Stage Liver Disease""; ""Coronary Artery Disease and Liver Transplantation""; ""Cardiac Arrhythmias and Liver Transplantation""; ""Valvular Heart Disease and Liver Transplantation""; ""Pulmonary Hypertension and Liver Transplantation""; ""Hypertrophic Obstructive Cardiomypathy in Liver Transplant Patients""; ""Obesity and Liver Transplantation""; ""Liver Disease and Chronic Advanced Heart Failure""; ""Combined Cardiac Surgery and Liver Transplantation""
""Previous Chemotherapy and Cardiac Function""""Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts""; ""Hepatopulmonary Syndrome""; ""Pre-Operative Assessment of Cardiovascular Function before Liver Transplantation: A Practical Approach""; ""A Role of Cardiopulmonary Exercise Testing (CPET) in Defining Cardiopulmonary Function before Liver Transplantation""; ""Pharmacotherapy of Cardiac Dysfunction in Liver Transplant Patients""; ""Cardiovascular Monitoring During Liver Transplantation"" ""Cardiovascular Profile and Cardiac Complications Following Liver Transplantation""""Acknowledgments""; ""Index"" |
| Record Nr. | UNINA-9910811519403321 |
| New York, : Nova Science, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The heart in systemic autoimmune diseases / / edited by Fabiola Atzeni, Rheumatology Unit, L. Sacco University Hospital, Milan Italy, Andrea Doria, Department of Medicine and Pheumatology Unit, University of Padova Medical School, Padova, Italy [and three others]
| The heart in systemic autoimmune diseases / / edited by Fabiola Atzeni, Rheumatology Unit, L. Sacco University Hospital, Milan Italy, Andrea Doria, Department of Medicine and Pheumatology Unit, University of Padova Medical School, Padova, Italy [and three others] |
| Autore | Atzeni Fabiola |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Amsterdam ; ; Cambridge, Massachusetts : , : Elsevier, , [2017] |
| Descrizione fisica | 1 online resource (xxiii, 542 pages) : illustrations (some color) |
| Disciplina | 616.1079 |
| Collana | Handbook of systemic autoimmune diseases |
| Soggetto topico |
Heart - Diseases - Immunological aspects
Autoimmune diseases Cardiological manifestations of general diseases Atherosclerosis - Immunological aspects Vasculitis |
| ISBN |
0-444-63669-2
0-12-803997-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover -- The Heart in Systemic Autoimmune Diseases -- Handbook of Systemic Autoimmune Diseases -- Handbook of Systemic Autoimmune Diseases -- Copyright -- Dedication -- Contents -- List of Contributors -- Preface -- 1 - Cellular Immunity: A Role for Cytokines -- 1. INTRODUCTION -- 2. AUTOIMMUNITY IN MYOCARDITIS -- 3. PATHOGENESIS: THE ROLE OF CELLS AND CYTOKINES -- 3.1 Viral Mouse Model -- 3.2 Cardiac Myosin Mouse Model -- 3.3 Role of Cells -- 3.4 Role of Cytokines -- 3.5 Summary of Pathogenic Mechanisms -- REFERENCES -- FURTHER READING -- 2 - Organ-Specific Autoimmunity Involvement in Cardiovascular Disease -- 1. INTRODUCTION -- 2. POST-MYOCARDIAL INFARCTION (DRESSLER) SYNDROME -- 2.1 Anti-Heart Autoantibodies -- 3. POST-PERICARDIOTOMY SYNDROME AND IDIOPATHIC RECURRENT ACUTE PERICARDITIS -- 3.1 Anti-Heart Autoantibodies -- 4. RHEUMATIC CARDITIS -- 4.1 Immune Pathogenesis of Rheumatic Carditis -- 4.1.1 Antistreptococcus Antibodies -- 4.1.2 Anti-heart Autoantibodies -- 5. DILATED CARDIOMYOPATHY AND MYOCARDITIS -- 5.1 Immune Pathogenesis of Myocarditis and Dilated Cardiomyopathy -- 5.2 Anti-Heart Autoantibodies by s-I IFL -- 5.3 Anti-Heart Autoantibodies by s-I IFL: Technical Considerations and Proposed Nomenclature -- 5.4 Autoantibodies to Myosin Heavy Chain and Other Autoantigens by Immunoblotting Techniques -- 5.5 Autoantibodies to Sarcolemmal Na-K-ATPase -- 5.6 Autoantibodies to Mitochondrial and to Extracellular Matrix Antigens -- 5.7 Blocking and Stimulating Autoantibodies to β-Adrenergic Receptors -- 5.8 Autoantibodies to M2-Muscarinic Receptors -- 5.9 Cardiac-Specific Antibodies in Myocarditis/DCM: Clinical Correlates and Potential Functional Role -- 6. IDIOPATHIC TACHY AND BRADYARRHYTHMIAS -- 6.1 Cardiac Conducting Tissue Antibodies -- 6.2 Stimulating Autoantibodies to β-Adrenergic Receptors -- 7. SYSTEMIC ARTERIAL HYPERTENSION.
7.1 Anti-Heart Autoantibodies by s-I IFL -- 7.2 Stimulating Autoantibodies to α1-Adrenergic Receptors -- 7.3 Stimulating Autoantibodies to the Angiotensin Receptor -- REFERENCES -- 3 - Neonatal Lupus Syndromes: Pathogenesis and Clinical Featuresa -- 1. INTRODUCTION -- 2. EPIDEMIOLOGY AND DEFINITION OF CONGENITAL COMPLETE AVB -- 3. ETIOLOGY/PATHOGENESIS -- 3.1 Myocarditis -- 3.2 Arrhythmogenesis and Electrophysiological Effects -- 3.3 Apoptosis, TGFbeta, TLR, and the Road to Scar -- 3.4 Genetics -- 3.5 Evaluation of the Fine Specificities of the Maternal Autoantibody Profile -- 3.6 Other Pathogenetic Mechanisms -- 4. RISK OF DELIVERING A CHILD WITH COMPLETE CHB -- 5. CLINICAL MANIFESTATIONS -- 5.1 Cardiac Manifestations -- 5.2 Non-Cardiac Manifestations -- 6. TREATMENT -- 6.1 Fluorinated Corticosteroids -- 6.2 Other Possible Therapies -- 6.3 Postnatal Treatment -- 7. OBSTETRIC MANAGEMENT OF PREGNANCIES AT RISK OF DEVELOPING CCHB -- 8. PROGNOSIS -- 8.1 Infants -- 8.2 Maternal -- 9. OTHER PREGNANCY OUTCOMES IN WOMEN WITH ANTI-RO/SSA ANTIBODIES -- 10. ANTI-RO/SSA NEGATIVE CHB -- ACKNOWLEDGMENT -- REFERENCES -- 4 - Subclinical Cardiovascular Damage in Systemic Rheumatic Diseases -- 1. INTRODUCTION -- 2. EPIDEMIOLOGY AND ROLE OF TRADITIONAL RISK FACTORS -- 2.1 Rheumatoid Arthritis -- 2.2 Systemic Lupus Erythematosus -- 2.3 Psoriatic Arthritis -- 2.4 Ankylosing Spondylitis -- 2.5 Systemic Sclerosis -- 3. SUBCLINICAL ATHEROSCLEROSIS -- 3.1 Rheumatoid Arthritis -- 3.2 Systemic Lupus Erythematosus -- 3.3 Psoriatic Arthritis -- 3.4 Ankylosing Spondylitis -- 3.5 Systemic Sclerosis -- 4. CARDIOVASCULAR EFFECTS OF PHARMACOLOGICAL TREATMENTS -- 4.1 Rheumatoid Arthritis -- 4.1.1 Nonsteroidal Antiinflammatory Drugs -- 4.1.2 Glucocorticoids -- 4.1.3 Nonbiologic Disease-Modifying Antirheumatic Drugs -- 4.1.4 Biologic Disease-Modifying Antirheumatic Drugs. 4.1.5 Statins -- 4.2 Systemic Lupus Erythematosus -- 4.2.1 Glucocorticoids -- 4.2.2 Hydroxychloroquine -- 4.2.3 Immunosuppressive Treatment -- 4.2.4 Statins -- 4.3 Psoriatic Arthritis -- 4.3.1 Biologic Disease-Modifying Antirheumatic Drugs -- 4.4 Ankylosing Spondylitis -- 4.4.1 Biologic Disease-Modifying Antirheumatic Drugs -- 4.4.2 Statins -- 4.5 Systemic Sclerosis -- REFERENCES -- 5 - Atherosclerosis and Autoimmunity -- 1. INTRODUCTION -- 2. PREVALENCE AND EPIDEMIOLOGY -- 3. PATHOGENESIS -- 3.1 Genetic Background -- 3.2 Subclinical Atherosclerosis: Endothelial Dysfunction and Atherosclerotic Plaque Formation -- 3.3 Autoantigens and Autoantibodies in Atherosclerosis -- 3.4 Cellular Mechanisms -- 3.5 The Role of β2GPI -- 3.6 Anticardiolipin Antibodies -- 3.7 Anti-oxLDL Antibodies -- 3.8 Anti-apoA-1 Antibodies -- 3.9 Inflammatory Chemokines and Cytokines in Autoimmune Atherosclerosis -- 3.10 Heat-Shock Proteins as Autoantigens in Atherosclerosis -- 3.11 Other Factors: Vitamin D and Obesity -- 3.12 Systemic Lupus Erythematosus and Atherosclerosis -- 3.13 Rheumatoid Arthritis and Atherosclerosis -- 4. CLINICAL MANIFESTATIONS -- 5. DIAGNOSTIC INVESTIGATIONS -- 6. TREATMENT -- REFERENCES -- 6 - Inflammasomes and Inflammatory Cytokines in Early Atherosclerosis -- 1. INTRODUCTION -- 2. LIPID DYSREGULATION IN AUTOIMMUNITY -- 3. INNATE IMMUNITY AND INFLAMMATORY SIGNALING MECHANISMS -- 4. INFLAMMASOMES AND IL-1β IN ATHEROGENESIS -- 5. β2-GLYCOPROTEIN I IN ATHEROGENIC INNATE IMMUNITY -- 6. SUMMARY AND CONCLUSIONS -- ACKNOWLEDGMENTS -- REFERENCES -- 7 - Treatment of Lipid Metabolism Disturbances in Autoimmune Diseases -- 1. INTRODUCTION -- 2. LIPID METABOLISM DISTURBANCES RELEVANT FOR ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN AUTOIMMUNE DISEASES -- 3. SERUM LIPID LEVEL CONTROL IN AUTOIMMUNE DISEASES -- 3.1 Diet and Nutraceuticals. 3.2 Total Cholesterol- and Low-Density Lipoprotein Cholesterol-Lowering Drugs: Statins -- 3.2.1 Potential and Proven Benefits of Statin Use in Patients With Autoimmune Diseases -- 3.2.1.1 Effects on the Autoimmune Disease -- 3.2.1.2 Effects on Lipid Metabolism and Cardiovascular Disease -- 3.2.2 Potential Harms of Statin Use in Patients With Autoimmune Diseases -- 3.3 Total Cholesterol- and Low-Density Lipoprotein Cholesterol-Lowering Drugs: Fibrates -- 3.4 High-Density Lipoprotein Cholesterol Increasing Drugs -- 4. LIPOPROTEIN FUNCTION MODULATION IN AUTOIMMUNE DISEASES -- REFERENCES -- 8 - Cardiac Imaging Techniques in Systemic Autoimmune Diseases -- 1. INTRODUCTION -- 2. TRANSTHORACIC ECHOCARDIOGRAPHY -- 3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY -- 4. STRESS ECHOCARDIOGRAPHY -- 5. TISSUE DOPPLER IMAGING -- 6. SPECKLE TRACKING ECHOCARDIOGRAPHY -- 7. MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY -- 8. USEFULNESS OF BIOMARKERS OF ENDOTHELIAL DYSFUNCTION -- 9. CAROTID ULTRASONOGRAPHY -- 9.1 Carotid Atherosclerosis -- 10. CONCLUSION -- REFERENCES -- FURTHER READING -- 9 - New Cardiac Imaging Tools and Invasive Techniques in Systemic Autoimmune Diseases (Part II) -- 1. INTRODUCTION -- 2. CARDIAC MAGNETIC RESONANCE IMAGING -- 2.1 Cardiac Magnetic Resonance Imaging Techniques -- 2.1.1 Cine Imaging -- 2.1.2 T2-Weighted Imaging -- 2.1.3 First-Pass Myocardial Perfusion Imaging -- 2.1.4 Late Gadolinium Enhancement Imaging -- 2.2 Clinical Role and Indications for Cardiac Magnetic Resonance Imaging -- 2.2.1 Ischemic Cardiomyopathy -- 2.2.2 Interstitial Fibrosis -- 2.2.3 Infiltrative Cardiomyopathies -- 2.2.4 Valve Dysfunction -- 2.2.5 Arrhythmogenic Right Ventricular Dysplasia -- 2.2.6 Constrictive Pericarditis -- 2.2.7 Inflammatory Vasculitis -- 3. COMPUTED TOMOGRAPHY -- 3.1 Coronary Calcium Scoring -- 3.2 Coronary Computed Tomography Angiography -- 3.3 Pericardial Disease. 4. RIGHT HEART CATHETERIZATION -- 5. ENDOMYOCARDIAL BIOPSY -- 5.1 Biopsy Technique -- 5.2 Complications -- 6. CONCLUSION -- ACKNOWLEDGMENT -- REFERENCES -- 10 - Cardiac Diseases in Rheumatoid Arthritis -- 1. INTRODUCTION -- 1.1 Rheumatoid Arthritis -- 1.2 Mortality in Rheumatoid Arthritis -- 2. ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS -- 2.1 Introduction -- 2.2 Epidemiology -- 2.3 Etiology of Ischaemic Heart Disease in Rheumatoid Arthritis -- 2.3.1 Traditional Cardiovascular Risk Factors -- 2.3.1.1 Hypertension -- 2.3.1.2 Smoking -- 2.3.1.3 Lipids -- 2.3.1.4 Insulin Resistance and Diabetes Mellitus -- 2.3.1.5 Physical Activity -- 2.3.1.6 Body Weight and Composition -- 2.3.2 Other Cardiovascular Risk Factors -- 2.4 Inflammation and Cardiovascular Disease in Rheumatoid Arthritis -- 2.5 Cardiovascular Risk Assessment in Rheumatoid Arthritis -- 2.5.1 Added Value of Novel Biomarkers and Imaging -- 2.6 Treatment -- 2.6.1 Antiinflammatory Therapy and Cardiovascular Risk -- 2.6.2 Treatment of Cardiovascular Risk Factors and Cardiovascular Disease in Rheumatoid Arthritis -- 3. NONATHEROSCLEROTIC CARDIOVASCULAR DISEASE -- 3.1 Pericardial Disease -- 3.1.1 Introduction -- 3.1.2 Prevalence -- 3.1.3 Etiology of Pericardial Involvement in Rheumatoid Arthritis -- 3.1.4 Mortality -- 3.1.5 Pathology -- 3.1.6 Clinical Manifestations -- 3.1.7 Diagnostic Investigations -- 3.1.8 Differential Diagnosis and Management -- 3.2 Endocardial Involvement in Rheumatoid Arthritis -- 3.2.1 Valvular Disease -- 3.2.2 Coronary Arteritis -- 3.3 Myocardial Involvement and Conduction System Abnormalities in Rheumatoid Arthritis -- 4. CONCLUSION -- REFERENCES -- 11 - Cardiac Involvement in Systemic Lupus Erythematosus -- 1. INTRODUCTION -- 2. PERICARDIAL INVOLVEMENT -- 2.1 Prevalence -- 2.2 Histopathologic Findings/Pathogenesis -- 2.3 Clinical Features. 2.4 Diagnostic Investigations. |
| Record Nr. | UNINA-9910583313103321 |
Atzeni Fabiola
|
||
| Amsterdam ; ; Cambridge, Massachusetts : , : Elsevier, , [2017] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
